PK/PD Relationship of the Monoclonal Anti-BAFF Antibody Tabalumab in Combination with Bortezomib in Patients with Previously Treated Multiple Myeloma: Comparison of Serum M-protein and Serum Free Light Chains as Predictors of Progression Free Survival

Author(s): P. Chanu, R. Bruno, L. Claret, D. B. Radtke, S. P. Carpenter, J. E. Wooldridge, D. M. Cronier
Year:

Learn More LinkedIn Twitter Facebook Email